SEATTLE (AP) _ CTI BioPharma Corp. (CTIC) on Thursday reported a loss of $14 million in its second quarter.

The Seattle-based company said it had a loss of 19 cents per share.

In the final minutes of trading on Thursday, the company's shares hit $1.33. A year ago, they were trading at 70 cents.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CTIC at https://www.zacks.com/ap/CTIC

Automated Insights, source Associated Press News